SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    T. H. C. Krüger, M. A. Wollmer, P. Negt, H. Frieling, S. Jung, K. G. Kahl, Inhalatives Loxapin zur Notfallbehandlung bei agitierten Patienten mit Borderline-Persönlichkeitsstörung, Der Nervenarzt, 2015,

    CrossRef

  2. 2
    Daniel A. Spyker, James V. Cassella, Randall R. Stoltz, Paul P. Yeung, Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo-controlled drug–drug interaction study, Pharmacology Research & Perspectives, 2015, 3, 6
  3. 3
    Kai G. Kahl, Philip Negt, Axel Wollmer, Stefanie Jung, Tillmann H. C. Kruger, Inhaled Loxapine for Acute Treatment of Agitation in Patients With Borderline Personality Disorder, Journal of Clinical Psychopharmacology, 2015, 35, 6, 741

    CrossRef

  4. 4
    T. Messer, F.-G. Pajonk, M.J. Müller, Pharmakotherapie von psychiatrischen Akut- und Notfallsituationen, Der Nervenarzt, 2015, 86, 9, 1097

    CrossRef

  5. 5
    Leslie Citrome, Jan Volavka, Preventing Violence in Patients with Schizophrenia, Current Treatment Options in Psychiatry, 2015, 2, 2, 182

    CrossRef

  6. 6
    M. Pook, W. Trägner, Maximilian Gahr, B.J. Connemann, C. Schönfeldt-Lecuona, Psychiatrische Notfälle im Notfall- und Rettungswesen, Notfall + Rettungsmedizin, 2015, 18, 3, 233

    CrossRef

  7. 7
    Dina Popovic, Philippe Nuss, Eduard Vieta, Revisiting loxapine: a systematic review, Annals of General Psychiatry, 2015, 14, 1

    CrossRef

  8. 8
    Gregor Hasler, Andreas Wolf, Toward stratified treatments for bipolar disorders, European Neuropsychopharmacology, 2015, 25, 3, 283

    CrossRef

  9. 9
    Caroline Parker, A brief summary of loxapine inhalation for rapid tranquillisation: what is its place in practice?, Journal of Psychiatric Intensive Care, 2014, 10, 02, 110

    CrossRef

  10. 10
    John Gar Yan Chan, Jennifer Wong, Qi Tony Zhou, Sharon Shui Yee Leung, Hak-Kim Chan, Advances in Device and Formulation Technologies for Pulmonary Drug Delivery, AAPS PharmSciTech, 2014, 15, 4, 882

    CrossRef

  11. 11
    Jan Volavka, Aggression in Psychoses, Advances in Psychiatry, 2014, 2014, 1

    CrossRef

  12. 12
    A. Wolf, M.J. Müller, F.-G.B. Pajonk, Psychopharmaka im Notarztdienst, Medizinische Klinik - Intensivmedizin und Notfallmedizin, 2014, 109, 1, 71

    CrossRef

  13. 13
    Nicholas Gross, Leon S. Greos, Eli O. Meltzer, Selwyn Spangenthal, Robert S. Fishman, Daniel A. Spyker, James V. Cassella, Safety and Tolerability of Inhaled Loxapine in Subjects with Asthma and Chronic Obstructive Pulmonary Disease—Two Randomized Controlled Trials, Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2014, 27, 6, 478

    CrossRef

  14. 14
    Leslie Citrome, Jan Volavka, The psychopharmacology of violence: making sensible decisions, CNS Spectrums, 2014, 19, 05, 411

    CrossRef

  15. 15
    Kimberly Nordstrom, Michael H. Allen, Alternative Delivery Systems for Agents to Treat Acute Agitation: Progress to Date, Drugs, 2013, 73, 16, 1783

    CrossRef

  16. 16
    Alexander Wolf, Matthias J. Müller, Frank-Gerald B. Pajonk, Impfungen im Alter, CME, 2013, 10, 12, 63

    CrossRef

  17. 17
    G. Juckel, Inhalatives Loxapin, Der Nervenarzt, 2013, 84, 9, 1113

    CrossRef

  18. 18
    Gillian M. Keating, Loxapine Inhalation Powder: A Review of its Use in the Acute Treatment of Agitation in Patients with Bipolar Disorder or Schizophrenia, CNS Drugs, 2013, 27, 6, 479

    CrossRef

  19. 19
    A. Wolf, M.J. Müller, F.-G.B. Pajonk, Psychopharmaka im Notarztdienst, Notfall + Rettungsmedizin, 2013, 16, 5, 397

    CrossRef

  20. 20
    A. Wolf, M.J. Müller, F.-G.B. Pajonk, Psychopharmakotherapie im Notarztdienst, Notfall + Rettungsmedizin, 2013, 16, 6, 477

    CrossRef

  21. 21
    A. Wolf, M.J. Müller, F.-G.B. Pajonk, Psychopharmakotherapie im Notarztdienst, Medizinische Klinik - Intensivmedizin und Notfallmedizin, 2013, 108, 8, 683

    CrossRef

  22. 22
    Glenn Currier, Patrick Walsh, Safety and Efficacy Review of Inhaled Loxapine for Treatment of Agitation, Clinical Schizophrenia & Related Psychoses, 2013, 7, 1, 25

    CrossRef

  23. 23
    Konstantinos N. Fountoulakis, Siegfried Kasper, Ole Andreassen, Pierre Blier, Ahmed Okasha, Emanuel Severus, Marcio Versiani, Rajiv Tandon, Hans-Jürgen Möller, Eduard Vieta, Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry, European Archives of Psychiatry and Clinical Neuroscience, 2012, 262, S1, 1

    CrossRef

  24. 24
    Kimberly Nordstrom, Inhaled loxapine for rapid treatment of agitation in schizophrenia and bipolar disorder: an update, Neuropsychiatry, 2012, 2, 3, 253

    CrossRef

  25. 25
    Cathleen M. Gould, Psychopharmacologic Treatment of Acute Agitation, Psychopharm Review, 2012, 47, 9, 65

    CrossRef